Article
Application of CRISPR-Cas9 gene editing for congenital heart disease
2 Mar 2021
Abstract excerpt
Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9 (CRISPR-Cas9) is an ancient prokaryotic defense system that precisely cuts foreign genomic DNA under the control of a small number of guide RNAs. The CRISPR-Cas9 system facilitates efficient double-stranded DNA cleavage that has been recently adopted for genome editing to create or correct inherited genetic mutations causing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
